Understanding the recovery patterns of patients with ARDS, pneumonia, and sepsis
Phenotyping ARDS, Pneumonia, and Sepsis over time to elucidate shared and distinct trajectories ofillness and recovery
This study is looking for people who have had serious breathing problems, like ARDS, pneumonia, or sepsis, to learn more about their recovery and find ways to better predict and improve their health outcomes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11086824 on NIH RePORTER |
What this research studies
This research focuses on enrolling patients who have experienced acute respiratory distress syndrome (ARDS), pneumonia, or sepsis to better understand their illness and recovery trajectories. By analyzing clinical and molecular features, the study aims to identify distinct subtypes of these conditions that can predict outcomes such as organ failure and long-term disability. Patients will be monitored over time, and their blood samples will be analyzed to uncover biomarkers associated with recovery and complications. This approach seeks to improve risk assessment and treatment strategies for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with ARDS, pneumonia, or sepsis.
Not a fit: Patients with chronic respiratory conditions unrelated to ARDS, pneumonia, or sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment plans and improved recovery outcomes for patients suffering from ARDS, pneumonia, and sepsis.
How similar studies have performed: Previous research has shown promise in identifying molecular subtypes in similar conditions, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Meyer, Nuala Jennings — University of Pennsylvania
- Study coordinator: Meyer, Nuala Jennings
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.